Total Payments
$713.17
2024 Payments
$32.28
Companies
11
Transactions
29
Medicare Patients
1,621
Medicare Billing
$538,120
Payment Breakdown by Category
Food & Beverage$713.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $713.17 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $124.70 | 1 | $0 (2022) |
| PFIZER INC. | $113.74 | 3 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $93.78 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $80.45 | 5 | $0 (2021) |
| La Jolla Pharmaceutical Company | $76.85 | 1 | $0 (2021) |
| Genentech USA, Inc. | $58.14 | 4 | $0 (2018) |
| AngioDynamics, Inc. | $54.99 | 3 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $54.58 | 3 | $0 (2018) |
| ABBVIE INC. | $23.47 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $18.26 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.28 | 2 | AngioDynamics, Inc. ($23.01) |
| 2023 | $104.45 | 6 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($62.72) |
| 2022 | $167.07 | 3 | AstraZeneca Pharmaceuticals LP ($124.70) |
| 2021 | $151.13 | 6 | La Jolla Pharmaceutical Company ($76.85) |
| 2020 | $131.31 | 4 | PFIZER INC. ($85.57) |
| 2018 | $41.65 | 3 | Actelion Pharmaceuticals US, Inc. ($14.65) |
| 2017 | $85.28 | 5 | Genentech USA, Inc. ($45.35) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/09/2024 | AngioDynamics, Inc. | BIOFLO (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: VA | ||||||
| 09/21/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/22/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/07/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/27/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.70 | General |
| Category: Rare Disease | ||||||
| 06/27/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/14/2022 | AngioDynamics, Inc. | BIOFLO (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: VA | ||||||
| 11/22/2021 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $76.85 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 09/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2021 | AngioDynamics, Inc. | BioFlo (Device) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: VA | ||||||
| 06/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/20/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/22/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/20/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $85.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Immunology | ||||||
| 06/12/2018 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 02/16/2018 | Philips Electronics North America Corporation | Respiratoriy Care Undiv (Device) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 393 | 784 | $971,452 | $116,763 |
| 2022 | 5 | 343 | 675 | $830,894 | $102,383 |
| 2021 | 6 | 448 | 1,004 | $1.2M | $157,119 |
| 2020 | 7 | 437 | 983 | $1.2M | $161,855 |
Total Patients
1,621
Total Services
3,446
Medicare Billing
$538,120
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 224 | 588 | $798,504 | $104,093 | 13.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 33 | 52 | $35,308 | $4,647 | 13.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 42 | 45 | $52,650 | $3,057 | 5.8% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 23 | 23 | $40,112 | $2,679 | 6.7% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 53 | 57 | $44,004 | $2,064 | 4.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 18 | 19 | $874.00 | $223.06 | 25.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 193 | 512 | $695,296 | $94,179 | 13.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 43 | 45 | $52,650 | $3,196 | 6.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 19 | 20 | $34,880 | $2,380 | 6.8% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 55 | 60 | $46,320 | $2,189 | 4.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 33 | 38 | $1,748 | $438.24 | 25.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 224 | 724 | $983,192 | $138,671 | 14.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 39 | 83 | $56,357 | $8,141 | 14.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 58 | 62 | $72,540 | $4,537 | 6.3% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 23 | 23 | $40,112 | $2,827 | 7.0% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 59 | 63 | $48,636 | $2,371 | 4.9% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 45 | 49 | $2,254 | $574.10 | 25.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 238 | 741 | $1.0M | $143,455 | 14.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 28 | 52 | $35,308 | $5,422 | 15.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 59 | 64 | $74,880 | $4,872 | 6.5% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 30 | 34 | $59,296 | $4,243 | 7.2% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 52 | 55 | $42,460 | $2,152 | 5.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 25 | $7,825 | $1,552 | 19.8% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2020 | 12 | 12 | $552.00 | $157.94 | 28.6% |
About Erwin Moy
Erwin Moy is a Pulmonary Disease healthcare provider based in Kendall Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1104145986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erwin Moy has received a total of $713.17 in payments from pharmaceutical and medical device companies, with $32.28 received in 2024. These payments were reported across 29 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($713.17).
As a Medicare-enrolled provider, Moy has provided services to 1,621 Medicare beneficiaries, totaling 3,446 services with total Medicare billing of $538,120. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Kendall Park, NJ
- Active Since 05/19/2010
- Last Updated 11/26/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1104145986
Products in Payments
- ANDEXXA (Biological) $124.70
- ELIQUIS (Drug) $113.74
- LifeVest (Device) $93.78
- XARELTO (Drug) $80.45
- XERAVA (Drug) $76.85
- Esbriet (Biological) $58.14
- BIOFLO (Device) $43.59
- OPSUMIT MACITENTAN (Drug) $39.93
- DALVANCE (Drug) $23.47
- LEQVIO (Drug) $18.26
- UPTRAVI (Drug) $14.65
- Respiratoriy Care Undiv (Device) $14.21
- BioFlo (Device) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.